SEC Form 4 · accession 0001127602-18-036571
Bausch Health Companies Inc. · BHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Appio
Officer — Pres&Co-Head Bausch&Lomb/Int'l
Period of report
Dec 14, 2018
Accepted (ET)
Dec 18, 2018 · 4:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000885590
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par ValueF1 | Dec 14, 2018 | P | 25,440 | $22.9567 | A | 128,922 | D | |
| Common Stock, No Par ValueF2 | Dec 14, 2018 | A | 25,440 | $0.00 | A | 154,362 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price in Column 4 is a weighted average price. The prices actually paid in this transaction are within the range of $22.94 to $22.96 per share. Upon request by the Commission staff, the Issuer or the reporting person will provide full information regarding the number of Common Shares purchased by the reporting person at each separate price within the range set forth in this footnote.
- F2Represents matching Restricted Share Units ("MRSUs") granted to the Reporting Person in connection with the open market purchase of Common Shares of the Issuer reported above (the "Purchased Shares"), pursuant to the Issuer's Matching Share Program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant ("MRSU Grant Date"), subject to the Reporting Person's continued service (except in limited circumstances).